COLE EYE INSTITUTE CLEVELAND CLINIC RETINA SUMMIT, Honolulu, Hawaii--April 27th--Dr. Allen Ho presented two lectures on "Surgical Drug Delivery" and "Gene Therapy for AMD and other Retinal Diseases". FIFTH ANNUAL INNOVATIVE SUMMIT FOR RETINAL CELL AND GENE THERAPY, Honolulu, Hawaii--April 27th--Dr. Allen Ho was also invited to speak at the Fifth Annual Innovative Summit for... read more
Dr. Sunir Garg conducted a clinical trial published in the the American Academy of Ophthalmology that assessed the ability of the Retina Implant Alpha AMS to restore vision in 6 patients with end-stage retinitis pigmentosa. Read the full study here.
Dr. Sunir Garg was interviewed by MedPage Today to discuss the concerns of cardiovascular adverse events with bevacizumab. Read the full article here.
Obeid A, Gao X, Ali FS, Allen C. Ho, MD, Jason Hsu MD, et al. Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti–Vascular Endothelial Growth Factor Injections. JAMA Ophthalmol.Published online August 23, 2018. doi:10.1001/jamaophthalmol.2018.3578 Dr. Allen Ho explains that by employing home monitoring technologies in patients at risk for progression... read more
Due to the impending weather on Wednesday, March 21st all Mid Atlantic Retina offices will be closed. The safety of our patients and our staff is our number one concern. If you had a scheduled appointment on March 21st you will receive a phone call from a Mid Atlantic Retina patient care liaison to reschedule.... read more
Hi I'm Taz and I am training to be a Guide Dog. I was born in June 2017 and named after Dr William Tasman, who was a really awesome doctor. The doctors and staff at Mid Atlantic Retina fundraised for 18 months to sponsor my training so I am super excited to share my experiences... read more
Due to the impending weather on Wednesday, March 7th, select Mid Atlantic Retina offices will operate under modified hours. If your appointment for Wednesday, March 7th is affected, you WILL receive a phone call from a Mid Atlantic Retina patient care liaison. If you DO NOT receive a phone call, please call the office prior... read more
Starting April 2018, Medicare will be issuing new Medicare cards to all eligible recipients. Make sure to bring your new Medicare card to your next appointment to assist in updating your insurance. To learn more about this change and why, please use this link. This short video also provides some details on the updated cards.... read more
Dr. Mitchell Fineman was on the field last night during the Eagles v Vikings NFC Championship Game and celebrated with the Eagles medical support team after Philly's NFC victory! Mid Atlantic Retina is the team ophthalmologist for the Philadelphia Eagles. #FlyEaglesFly
Mid Atlantic Retina is pleased that the FDA has approved gene therapy, voretigene (Luxturna), for very specific uncommon genetic retinal diseases, caused by mutations in the gene RPE65 which may cause a form of Leber Congenital Amaurosis or retinitis pigmentosa. These disorders cause severe loss of vision starting at birth or in early childhood. Not... read more